Pfizer Forgoes Fees To Close Accupril Suit

Law360, New York (July 9, 2008, 12:00 AM EDT) -- A Pfizer Inc. subsidiary has ended its decade-old dispute with Teva Pharmaceuticals USA Inc. over the hypertension drug Accupril by dropping attorneys' fees and willful infringement claims in exchange for Teva dropping its appeal of a finding that the generics maker infringed Pfizer's patent.

Judge Dickinson R. Debevoise of the U.S. District Court for the District of New Jersey dismissed the case with prejudice Monday after Warner-Lambert Co. and Teva inked agreements last month dropping the appeal and the additional claims, which were bifurcated from the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.